These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 7707812)
1. Screening for active tuberculosis in HIV testing centre. Espinal MA; Reingold AL; Koenig E; Lavandera M; Sanchez S Lancet; 1995 Apr; 345(8954):890-3. PubMed ID: 7707812 [TBL] [Abstract][Full Text] [Related]
2. Tuberculin sensitivity and HIV-1 status of patients attending a sexually transmitted diseases clinic in Lusaka, Zambia: a cross-sectional study. Duncan LE; Elliott AM; Hayes RJ; Hira SK; Tembo G; Mumba GT; Ebrahim SH; Quigley M; Pobee JO; McAdam KP Trans R Soc Trop Med Hyg; 1995; 89(1):37-40. PubMed ID: 7747304 [TBL] [Abstract][Full Text] [Related]
3. A prospective study of the risk of tuberculosis among HIV-infected patients. Guelar A; Gatell JM; Verdejo J; Podzamczer D; Lozano L; Aznar E; Miró JM; Mallolas J; Zamora L; González J AIDS; 1993 Oct; 7(10):1345-9. PubMed ID: 8267907 [TBL] [Abstract][Full Text] [Related]
4. Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre. Aisu T; Raviglione MC; van Praag E; Eriki P; Narain JP; Barugahare L; Tembo G; McFarland D; Engwau FA AIDS; 1995 Mar; 9(3):267-73. PubMed ID: 7755915 [TBL] [Abstract][Full Text] [Related]
5. A comparison of clinical features in tuberculosis associated with infection with human immunodeficiency viruses 1 and 2. Gnaore E; Sassan-Morokro M; Kassim S; Ackah A; Yesso G; Adjorlolo G; Digbeu H; Coulibaly D; Coulibaly IM; Doorly R Trans R Soc Trop Med Hyg; 1993; 87(1):57-9. PubMed ID: 8385370 [TBL] [Abstract][Full Text] [Related]
6. The impact of HIV on infectiousness of pulmonary tuberculosis: a community study in Zambia. Elliott AM; Hayes RJ; Halwiindi B; Luo N; Tembo G; Pobee JO; Nunn PP; McAdam KP AIDS; 1993 Jul; 7(7):981-7. PubMed ID: 8357557 [TBL] [Abstract][Full Text] [Related]
7. Effect of pregnancy on the risk of developing active tuberculosis. Espinal MA; Reingold AL; Lavandera M J Infect Dis; 1996 Feb; 173(2):488-91. PubMed ID: 8568319 [TBL] [Abstract][Full Text] [Related]
8. Tuberculosis in HIV infection. Horner PJ; Moss FM Int J STD AIDS; 1991; 2(3):162-7. PubMed ID: 1863645 [TBL] [Abstract][Full Text] [Related]
9. The impact of the HIV epidemic on tuberculosis control programmes in developing countries. Veeken H; Bermejo A Trop Doct; 1992 Apr; 22(2):64-7. PubMed ID: 1344023 [TBL] [Abstract][Full Text] [Related]
10. Tuberculosis and human immunodeficiency virus infection in developing countries. Harries AD Lancet; 1990 Feb; 335(8686):387-90. PubMed ID: 1968123 [TBL] [Abstract][Full Text] [Related]
11. Predictive markers of survival in HIV-seropositive and HIV-seronegative Tanzanian patients with extrapulmonary tuberculosis. Richter C; Koelemay MJ; Swai AB; Perenboom R; Mwakyusa DH; Oosting J Tuber Lung Dis; 1995 Dec; 76(6):510-7. PubMed ID: 8593371 [TBL] [Abstract][Full Text] [Related]
12. Anergy skin testing and tuberculosis [corrected] preventive therapy for HIV-infected persons: revised recommendations. Centers for Disease Control and Prevention. MMWR Recomm Rep; 1997 Sep; 46(RR-15):1-10. PubMed ID: 9332982 [TBL] [Abstract][Full Text] [Related]
13. Spectrum of immunodeficiency in HIV-1-infected patients with pulmonary tuberculosis in Zaire. Mukadi Y; Perriëns JH; St Louis ME; Brown C; Prignot J; Willame JC; Pouthier F; Kaboto M; Ryder RW; Portaels F Lancet; 1993 Jul; 342(8864):143-6. PubMed ID: 8101257 [TBL] [Abstract][Full Text] [Related]
14. Tuberculin skin test reactivity, anergy, and HIV infection in hospitalized patients. Longcope Firm of the Osler Medical Housestaff. Janis EM; Allen DW; Glesby MJ; Carey LA; Mundy LM; Gopalan R; Chaisson RE Am J Med; 1996 Feb; 100(2):186-92. PubMed ID: 8629653 [TBL] [Abstract][Full Text] [Related]
15. Infectiousness of Mycobacterium tuberculosis in HIV-1-infected patients with tuberculosis: a prospective study. Espinal MA; Peréz EN; Baéz J; Hénriquez L; Fernández K; Lopez M; Olivo P; Reingold AL Lancet; 2000 Jan; 355(9200):275-80. PubMed ID: 10675075 [TBL] [Abstract][Full Text] [Related]
16. HIV does not increase infectivity of M. tuberculosis. AIDS Wkly; 2000 Feb; ():2-3. PubMed ID: 12295705 [TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus infection in children with tuberculosis in Santo Domingo, Dominican Republic: prevalence, clinical findings, and response to antituberculosis treatment. Espinal MA; Reingold AL; Pérez G; Camilo E; Soto S; Cruz E; Matos N; Gonzalez G J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Oct; 13(2):155-9. PubMed ID: 8862280 [TBL] [Abstract][Full Text] [Related]
18. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. Selwyn PA; Sckell BM; Alcabes P; Friedland GH; Klein RS; Schoenbaum EE JAMA; 1992 Jul 22-29; 268(4):504-9. PubMed ID: 1619742 [TBL] [Abstract][Full Text] [Related]
19. Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Pape JW; Jean SS; Ho JL; Hafner A; Johnson WD Lancet; 1993 Jul; 342(8866):268-72. PubMed ID: 8101302 [TBL] [Abstract][Full Text] [Related]
20. Tuberculosis vaccination versus isoniazid preventive therapy: a decision analysis to determine the preferred strategy of tuberculosis prevention in HIV-infected adults in the developing world. Sterling TR; Brehm WT; Moore RD; Chaisson RE Int J Tuberc Lung Dis; 1999 Mar; 3(3):248-54. PubMed ID: 10094327 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]